Literature DB >> 2155000

Leukotriene B4 in inflammation.

A W Ford-Hutchinson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2155000

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN： 1040-8401            Impact factor:   2.214


× No keyword cloud information.
  51 in total

1.  Role of FLAP and PDE4D in myocardial infarction and stroke: target discovery and future treatment options.

Authors:  Hakon Hakonarson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

3.  Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.

Authors:  Federico Díaz-González; Rieke H E Alten; William G Bensen; Jacques P Brown; John T Sibley; Maxime Dougados; Stefano Bombardieri; Patrick Durez; Pablo Ortiz; Gonzalo de-Miquel; Alexander Staab; Ralf Sigmund; Laurence Salin; Caroline Leledy; Stephen H Polmar
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

4.  Chemotactic factors released in culture by intact developing and healing skin lesions produced in rabbits by the irritant sulfur mustard.

Authors:  F Tanaka; A M Dannenberg; K Higuchi; M Nakamura; P J Pula; T E Hugli; R G Discipio; D L Kreutzer
Journal:  Inflammation       Date:  1997-04       Impact factor: 4.092

Review 5.  PPARalpha: energy combustion, hypolipidemia, inflammation and cancer.

Authors:  Sean R Pyper; Navin Viswakarma; Songtao Yu; Janardan K Reddy
Journal:  Nucl Recept Signal       Date:  2010-04-16

Review 6.  Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer.

Authors:  Sayeh Savari; Katyayni Vinnakota; Yuan Zhang; Anita Sjölander
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

7.  Activation of the human neutrophil 5-lipoxygenase by leukotriene B4.

Authors:  P P McDonald; S R McColl; P H Naccache; P Borgeat
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

Review 8.  Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.

Authors:  Mairi C Noverr; John R Erb-Downward; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

9.  Novel 3-hydroxylated leukotriene b4 metabolites from ethanol-treated rat hepatocytes.

Authors:  M A Shirley; R C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  1992-10       Impact factor: 3.109

10.  Pharmacological control of neutrophil-mediated inflammation: strategies targeting calcium handling by activated polymorphonuclear leukocytes.

Authors:  Gregory R Tintinger; Helen C Steel; Annette J Theron; Ronald Anderson
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.